GP23

GP23 decreases frailty in silico (β -0.119, 95% CI -0.219 to -0.019).

“suggestive evidence was found for GP23 and FI (β -0.119, 95% CI -0.219 to -0.019, p = 0.019)”

In silico

The Causality between Human Immunoglobulin G (IgG) N-Glycosylation and Aging: A Mendelian Randomization Study

Molecules (Basel, Switzerland)·14 Mar 2024